3
Announcements
Trials
Browse
Landscape
Status
Recruiting
20
Active not recruiting
17
Completed
5
Terminated
4
Not yet recruiting
4
Withdrawn
1
Suspended
1
Available
1
Sponsor Class
INDUSTRY
1
Study Type
Expanded_access
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Conditions
Sarcoma
1
Primary Myelofibrosis
1
Multiple Myeloma
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Large B-Cell, Diffuse
1
Endometrial Neoplasms
1
Interventions
balstilimab
2
3-Iodobenzylguanidine
2
zolbetuximab
1
zipalertinib
1
venetoclax
1
ulixertinib
1
tisagenlecleucel
1
tipifarnib
1
talazoparib
1
selinexor
1
ruxolitinib
1
ribociclib
1
nirogacestat
1
mirdametinib
1
mifamurtide
1
lifileucel
1
leronlimab
1
idecabtagene vicleucel
1
fluorodopa F 18
1
fluorocholine
1
dodecyl maltoside
1
carbon-11 methionine
1
brexucabtagene autoleucel
1
axicabtagene ciloleucel
1
asciminib
1
Sunitinib
1
Proton Pump Inhibitors
1
Peripheral Blood Stem Cell Transplantation
1
Methionine
1
Magnetic Resonance Spectroscopy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Available
×
selinexor
×
1 year
×
Clear all
NCT07215832
2026-03-02
KEAP
Karyopharm Therapeutics Inc
Available